Numerion Labs

Innovative Approaches in Drug Discovery Using Machine Learning

San Francisco, United States · Founded 2012 · $202.8M raised

Founded
2012
Business Model
B2B
Total Funding
$202.8M
Last Round
$19.8M Series DMar 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Numerion Labs, formerly known as Atomwise, is an AI-native drug discovery company founded by Abraham Heifets that unites computational chemistry, structural biology, and medicinal chemistry into an AI superplatform exploring chemical space to discover novel small-molecule drugs. Its programs target immune and inflammatory diseases, and the company has published research with NVIDIA on ultra-fast screening of hyper-scalable virtual compound libraries using its APEX search protocol.

Summary

Numerion Labs is an Artificial Intelligence company based in San Francisco, United States, founded in 2012. It has raised $202.8M in total across 5 rounds, most recently a $19.8M Series D round in Mar 2026. Investors include DCVC (Data Collab), Y Combinator and B Capital Group.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DMar 2026
$19.8M

Sign up to see all 5 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Numerion Labs on Indexed.vc
<a href="https://indexed.vc/companies/numerion-labs"><img src="https://indexed.vc/api/badge/company/numerion-labs" alt="Numerion Labs on Indexed.vc" width="260" height="76" /></a>